$5.14
Live
0.92%
Downside
Day's Volatility :5.69%
Upside
4.81%
82.1%
Downside
52 Weeks Volatility :83.8%
Upside
9.51%
Period | Omeros Corporation | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 67.62% | 6.5% | 0.0% |
6 Months | 60.49% | 7.1% | 0.0% |
1 Year | 19.73% | 9.8% | 0.0% |
3 Years | -63.28% | 14.2% | -20.2% |
Market Capitalization | 316.4M |
Book Value | - $1.23 |
Earnings Per Share (EPS) | -2.81 |
PEG Ratio | -0.17 |
Wall Street Target Price | 43.0 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -21.03% |
Return On Equity TTM | -576.33% |
Revenue TTM | -30.0M |
Revenue Per Share TTM | -0.48 |
Quarterly Revenue Growth YOY | 14.899999999999999% |
Gross Profit TTM | -71.4M |
EBITDA | -166.9M |
Diluted Eps TTM | -2.81 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -2.41 |
EPS Estimate Next Year | -1.98 |
EPS Estimate Current Quarter | -0.58 |
EPS Estimate Next Quarter | -0.56 |
What analysts predicted
Upside of 736.58%
Sell
Neutral
Buy
Omeros Corporation is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Omeros Corporation | 38.22% | 60.49% | 19.73% | -63.28% | -65.74% |
![]() Moderna, Inc. | -1.67% | 18.26% | -0.21% | -64.15% | 752.69% |
![]() Regeneron Pharmaceuticals, Inc. | -0.46% | 13.21% | 45.59% | 84.19% | 244.2% |
![]() Novo Nordisk A/s | -11.0% | 18.31% | 61.56% | 186.46% | 423.59% |
![]() Vertex Pharmaceuticals Incorporated | 3.85% | 14.43% | 39.88% | 147.45% | 195.07% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Omeros Corporation | 1.43 | NA | -0.17 | -2.41 | -5.76 | -0.21 | NA | -1.23 |
![]() Moderna, Inc. | 24.73 | NA | 0.0 | -7.19 | -0.38 | -0.16 | NA | 33.47 |
![]() Regeneron Pharmaceuticals, Inc. | 31.35 | 31.35 | 1.46 | 44.44 | 0.15 | 0.08 | NA | 250.15 |
![]() Novo Nordisk A/s | 44.28 | 44.28 | 2.36 | 3.43 | 1.0 | 0.25 | 0.01 | 22.18 |
![]() Vertex Pharmaceuticals Incorporated | 31.85 | 31.85 | 0.53 | 16.98 | 0.24 | 0.13 | NA | 71.8 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Omeros Corporation | Buy | $316.4M | -65.74% | 1.43 | 0.0% |
![]() Moderna, Inc. | Buy | $45.3B | 752.69% | 24.73 | -115.82% |
![]() Regeneron Pharmaceuticals, Inc. | Buy | $116.9B | 244.2% | 31.35 | 29.45% |
![]() Novo Nordisk A/s | Buy | $572.0B | 423.59% | 44.28 | 36.55% |
![]() Vertex Pharmaceuticals Incorporated | Buy | $126.7B | 195.07% | 31.85 | 39.46% |
Insights on Omeros Corporation
In the last 1 year, Novo Nordisk A/s has given 61.6% return, outperforming this stock by 41.9%
In the last 3 years, Novo Nordisk A/s has given 186.5% return, outperforming this stock by 249.8%
Ingalls & Snyder LLC
BlackRock Inc
Vanguard Group Inc
Stifel Financial Corp
D. E. Shaw & Co LP
Geode Capital Management, LLC
omeros is a seattle-based biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system.
Organization | Omeros Corporation |
Employees | 198 |
CEO | Dr. Gregory A. Demopulos M.D. |
Industry | Health Technology |
A Spac I Acquisition Corp
$5.14
-2.65%
Keyarch Acquisition Corp
$5.14
-2.65%
Connexa Sports Technologies Inc
$5.14
-2.65%
Us Value Etf
$5.14
-2.65%
First Wave Biopharma Inc
$5.14
-2.65%
Global X Msci Next Emerging
$5.14
-2.65%
Fat Projects Acquisition Corp
$5.14
-2.65%
Capital Link Global Fintech
$5.14
-2.65%
Applied Uv Inc
$5.14
-2.65%